Literature DB >> 6823056

Middle ear disease and the practice of pediatrics. Burden during the first five years of life.

D W Teele, J O Klein, B Rosner, L Bratton, G R Fisch, O R Mathieu, P J Porter, S G Starobin, L D Tarlin, R P Younes.   

Abstract

To determine the burden on pediatricians imposed by disease of the middle ear, we analyzed data from 2,570 children followed up prospectively since birth. Disease of the middle ear accounted for a large proportion of all visits made during the first five years of life, rising from 22.7% during the first year to about 40% in years 4 and 5. About one visit in three made for illness of any kind resulted in the diagnosis of disease of the middle ear. Approximately three fourths of all visits to follow up any illness were made to follow up disease of the middle ear. Disease of the middle ear was diagnosed at between 5% and 10% of all well-baby visits. Children from private practice averaged fewer visits for all reasons than did children using a large neighborhood health center, but the proportions of visits accounted for by disease of the middle ear were similar in both settings.

Entities:  

Mesh:

Year:  1983        PMID: 6823056

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  19 in total

Review 1.  Clinical considerations in the diagnosis of otitis media.

Authors:  Monte R Klaudt; William J Steinbach; Theodore C Sectish
Journal:  Curr Allergy Asthma Rep       Date:  2003-07       Impact factor: 4.806

2.  Novel sialic acid transporter of Haemophilus influenzae.

Authors:  Simon Allen; Anthony Zaleski; Jason W Johnston; Bradford W Gibson; Michael A Apicella
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Multiple consecutive lavage samplings reveal greater burden of disease and provide direct access to the nontypeable Haemophilus influenzae biofilm in experimental otitis media.

Authors:  Magali Leroy; Howard Cabral; Marisol Figueira; Valérie Bouchet; Heather Huot; Sanjay Ram; Stephen I Pelton; Richard Goldstein
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

4.  Tympanostomy tube placement and vestibular function in children.

Authors:  Michael S Cohen; Ellen M Mandel; Joseph M Furman; Patrick J Sparto; Margaretha L Casselbrant
Journal:  Otolaryngol Head Neck Surg       Date:  2011-06-15       Impact factor: 3.497

5.  Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era.

Authors:  Ravinder Kaur; Matthew Morris; Michael E Pichichero
Journal:  Pediatrics       Date:  2017-08-07       Impact factor: 7.124

6.  Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media.

Authors:  Valérie Bouchet; Derek W Hood; Jianjun Li; Jean-Robert Brisson; Gaynor A Randle; Adèle Martin; Zhong Li; Richard Goldstein; Elke K H Schweda; Stephen I Pelton; James C Richards; E Richard Moxon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-10       Impact factor: 11.205

7.  Drug prescription in young children: results of a survey in France. Epicrèche Research Group.

Authors:  J P Collet; N Bossard; D Floret; J Gillet; D Honegger; J P Boissel
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

8.  Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae.

Authors:  J Qiu; D R Hendrixson; E N Baker; T F Murphy; J W St Geme; A G Plaut
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

9.  In vitro activity of orally administered antimicrobial agents against Haemophilus influenzae recovered from children monitored longitudinally in a group day-care center.

Authors:  M J George; B Kitch; F W Henderson; P H Gilligan
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

10.  Prospective study of antibiotic prescribing for children.

Authors:  R A Pennie
Journal:  Can Fam Physician       Date:  1998-09       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.